Jennison Associates’s Burning Rock Biotech BNR Stock Holding History

Jennison Associates’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-56,778	Closed	-$10.2M	–	663
2021 Q3	$10.2M	Sell	56,778 -113,203	-67%	-$25.2M	0.01%	452
2021 Q2	$50.1M	Sell	169,981 -23,627	-12%	-$6.99M	0.03%	222
2021 Q1	$52.1M	Buy	193,608 +11,226	+6%	+$3.42M	0.04%	215
2020 Q4	$42.1M	Buy	182,382 +121,871	+201%	+$32.7M	0.03%	234
2020 Q3	$15.2M	Buy	60,511 +13,306	+28%	+$3.15M	0.01%	336
2020 Q2	$12.8M	Buy	+47,205	New	+$12.9M	0.01%	341

Other funds holding BNR

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates's BNR Position: Q4 2021 in Review

Jennison Associates sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 56,778 shares — an estimated $10.2M sold.

Jennison Associates first reported a position in BNR in Q2 2020 and held it in 6 quarters. The position peaked at $52.1M in Q1 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

Jennison Associates reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
Jennison Associates sold 56,778 Burning Rock Biotech shares in Q4 2021, an estimated $10.2M.
Jennison Associates first reported a position in Burning Rock Biotech in Q2 2020 and held it in 6 quarters.
Jennison Associates's Burning Rock Biotech position peaked at $52.1M in Q1 2021.
62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on Jennison Associates's 13F filing for Q4 2021, filed 8 Feb 2022.